Skip to content
NCCPDI_Long
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Menu
  • About Us
    • Mission & Goals
    • Team
    • Partners
    • FAQs
  • Resources
    • Consulting
    • Pediatric Device Events
    • Media
  • NCC-PDI Competition
  • Projects
  • Contact Us
Search
Close

New trial will assess MR-HIFU, chemo drug combo

  • November 16, 2016
Read More...

New trial will assess MR-HIFU, chemo drug combo

Share on facebook
Facebook
Share on google
Google+
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
PrevPreviousChildren’s National and Celsion Announce Clinical Study to Treat Recurrent Childhood Tumors
NextNew Study Identifies Which Physical Features Are Best Indicators of Down Syndrome in Diverse PopulationsNext
Innovate4Kids

The National Capital Consortium for Pediatric Device Innovation (NCC-PDI) serves as a critical device development resource by providing expert advice, support services, and fund management of pediatric device innovation.

About Us

  • Mission & Goals
  • Team
  • Partners
  • FAQs
  • Privacy Policy

Resources

  • Consulting
  • Pediatric Device Events

Contact Us

NCC-PDI@childrensnational.org

© All rights reserved